Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Free Access

Novel Insights into Lithium’s Mechanism of Action: Neurotrophic and Neuroprotective Effects

Quiroz J.A.a · Machado-Vieira R.b · Zarate, Jr. C.A.b · Manji H.K.c

Author affiliations

aHoffman-La Roche Inc., Pharma Development and Exploratory Neuroscience, Nutley, N.J., bExperimental Therapeutics, Mood and Anxiety Disorders Research Program, NIMH-NIH, Bethesda, Md., and cJohnson & Johnson Pharmaceutical Research and Development, L.L.C., Titusville, N.J., USA

Corresponding Author

Husseini K. Manji, MD, FRCPC

Johnson & Johnson Pharmaceuticals Group

1125 Trenton-Harbourton Road, E32000

Titusville, NJ 08560 (USA)

Tel. +1 609 730 2968, Fax +1 609 730 2940, E-Mail hmanji@its.jnj.com

Related Articles for ""

Neuropsychobiology 2010;62:50–60

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


The monovalent cation lithium partially exerts its effects by activating neurotrophic and neuroprotective cellular cascades. Here, we discuss the effects of lithium on oxidative stress, programmed cell death (apoptosis), inflammation, glial dysfunction, neurotrophic factor functioning, excitotoxicity, and mitochondrial stability. In particular, we review evidence demonstrating the action of lithium on cyclic adenosine monophosphate (cAMP)-mediated signal transduction, cAMP response element binding activation, increased expression of brain-derived neurotrophic factor, the phosphatidylinositide cascade, protein kinase C inhibition, glycogen synthase kinase 3 inhibition, and B-cell lymphoma 2 expression. Notably, we also review data from clinical studies demonstrating neurotrophic effects of lithium. We expect that a better understanding of the clinically relevant pathophysiological targets of lithium will lead to improved treatments for those who suffer from mood as well as neurodegenerative disorders.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: May 07, 2010
Issue release date: June 2010

Number of Print Pages: 11
Number of Figures: 1
Number of Tables: 0

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: http://www.karger.com/NPS

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.